Incidence, risk factors and sequelae of long/post-COVID in people with diabetes compared to people without diabetes in Germany (longcovid-diab): a study protocol
Study context
- Population
- Persons with statutory health insurance in Germany (Health Data Lab billing data), 2021–2023
- Planned comparison
- People with diabetes vs people without diabetes
- Primary endpoint
- Incidence and time trends of Long/Post-COVID in people with and without diabetes, compared as relative risk
Methodological detailsnon-interventional, nationwide, population-based, statutory health insurance data, Planned: age- and sex-standardized mortality and hospitalization rates (any; acute MI, stroke, amputation, diabetic foot syndrome) within 12, 24 and 36 months after Long/Post-COVID diagnosis, 2021–2024, Sensitivity analyses for diagnostic uncertainty (e.g., underreporting)
- Non-interventional
- Nationwide
- Population-based
- Statutory health insurance data
- Planned: age- and sex-standardized mortality and hospitalization rates (any; acute MI, stroke, amputation, diabetic foot syndrome) within 12, 24 and 36 months after Long/Post-COVID diagnosis, 2021–2024
- Sensitivity analyses for diagnostic uncertainty (e.g., underreporting)
No results yet. This paper sets out the design of a trial; its results are to come.
Original publication
Incidence, risk factors and sequelae of long/post-COVID in people with diabetes compared to people without diabetes in Germany (longcovid-diab): a study protocol. Cardiovasc Diabetol. Published 28 May 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →